Detalles de la búsqueda
1.
A non-interventional, observational study of a fixed combination of pepsin and amino acid hydrochloride in patients with functional dyspepsia.
BMC Gastroenterol
; 17(1): 123, 2017 Nov 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-29178842
2.
Safety and Efficacy of a Novel Microbial Lipase in Patients with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis: A Randomized Controlled Clinical Trial.
J Pediatr
; 176: 156-161.e1, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27297209
3.
Pharmacokinetic and Pharmacodynamic Characteristics of Subcutaneously Applied PTH-1-37.
Kidney Blood Press Res
; 41(5): 507-518, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27487342
4.
A Modular Approach to Combine Postmarket Clinical Follow-Up Studies and Postmarket Surveillance Studies.
Methods Inf Med
; 60(3-04): 116-122, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34450668
5.
Safety and tolerability of a new formulation of pancrelipase delayed-release capsules (CREON) in children under seven years of age with exocrine pancreatic insufficiency due to cystic fibrosis: an open-label, multicentre, single-treatment-arm study.
Clin Drug Investig
; 30(6): 351-64, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20441244
6.
Clinical implications of residual growth hormone (GH) response to provocative testing in adults with severe GH deficiency.
J Clin Endocrinol Metab
; 92(7): 2604-9, 2007 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17488801
7.
Effects of the renal natriuretic peptide urodilatin (ularitide) in patients with decompensated chronic heart failure: a double-blind, placebo-controlled, ascending-dose trial.
Am Heart J
; 150(6): 1239, 2005 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-16338265
8.
Administration of CREON® pancrelipase pellets via gastrostomy tube is feasible with no loss of gastric resistance or lipase activity: an in vitro study.
Clin Drug Investig
; 31(7): e1-7, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21627335
Resultados
1 -
8
de 8
1
Próxima >
>>